All known lymph node metastases could be visualized, and significantly higher uptake in lymph node metastases in patients with HER2-positive lesions versus patients with HER2-low/negative lesions was observed. The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.